SHINE Medical Technologies, LLC, 65424-65426 [2019-25788]

Download as PDF 65424 Federal Register / Vol. 84, No. 229 / Wednesday, November 27, 2019 / Notices additional credit reduction applied for calendar year 2019. However, as a result of having outstanding advances on each January 1 of 2010 through 2019, which had outstanding balances on November 10, 2019, employers in USVI are subject to a FUTA credit reduction of 2.7 percent in 2019. John Pallasch, Assistant Secretary for Employment and Training. security research community to report vulnerabilities to appropriate agency contacts, who can then use the reports to address vulnerabilities of which they may not have been aware. Authority for this notice is granted under the Federal Information Security Modernization Act of 2014 (44 U.S.C. 3553–3554). Suzette Kent, Federal Chief Information Officer, Office of the Federal Chief Information Officer. [FR Doc. 2019–25742 Filed 11–26–19; 8:45 am] BILLING CODE 4510–FW–P Office of Management and NATIONAL FOUNDATION ON THE ARTS AND THE HUMANITIES National Endowment for the Humanities NUCLEAR REGULATORY COMMISSION [Docket No. 50–608; NRC–2019–0173] Humanities Panel Advisory Committee Notice of public comment period. National Endowment for the Humanities; National Foundation on the Arts and the Humanities. AGENCY: The Office of Management and Budget (OMB) is seeking public comment on a draft memorandum titled, ‘‘Improving Vulnerability Identification, Management, and Remediation.’’ DATES: The 30-day public comment period on the draft memorandum begins on the day it is published in the Federal Register and ends 30 days after date of publication in the Federal Register. ADDRESSES: Interested parties should provide comments via electronic mail to ofcio@omb.eop.gov. The Office of Management and Budget is located at 725 17th Street NW, Washington, DC 20503. No physical copies will be accepted. SUMMARY: FOR FURTHER INFORMATION CONTACT: Matthew T. Cornelius, OMB, at 202.881.7386 or matthew.t.cornelius@ omb.eop.gov. The Office of Management and Budget (OMB) is proposing guidance to Federal agencies on the publication and implementation of Vulnerability Disclosure Policies (VDPs). VDPs, which are processes for the intake and addressing of security vulnerabilities uncovered by security researchers and the public, are among the most effective methods for obtaining new insights regarding security vulnerability information. They also provide protection for those who uncover these vulnerabilities by differentiating between acceptable and unacceptable means of gathering security information (also known as ‘‘authorizing good faith security research’’). VDPs make it easier for the SUPPLEMENTARY INFORMATION: Jkt 250001 Nuclear Regulatory Commission. ACTION: Intent to prepare a supplement to the final environmental impact statement and conduct scoping. Notice of Charter Renewal for Humanities Panel advisory committee. ACTION: The National Endowment for the Humanities (NEH) gives notice that the Charter for the Humanities Panel advisory committee was renewed for an additional two-year period on November 22, 2019. SUMMARY: FOR FURTHER INFORMATION CONTACT: Elizabeth Voyatzis, Committee Management Officer, 400 Seventh Street SW, Washington, DC 20506. Telephone: (202) 606–8322, facsimile (202) 606– 8600, or email at gencounsel@neh.gov. Hearing-impaired individuals are advised that information on this matter may be obtained by contacting the National Endowment for the Humanities’ TDD terminal at (202) 606– 8282. Pursuant to section 9(a)(2) of the Federal Advisory Committee Act (5 U.S.C. App.) and its implementing regulations, 41 CFR 102–3.65, the National Endowment for the Humanities (NEH) gives notice that the Charter for the Humanities Panel advisory committee was renewed for an additional two-year period on November 22, 2019. The NEH Chairman determined that the renewal of the Humanities Panel is necessary and in the public interest in connection with the performance of duties imposed upon the Chairperson of NEH by the National Foundation on the Arts and the SUPPLEMENTARY INFORMATION: PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 The U.S. Nuclear Regulatory Commission (NRC) intends to gather information through the public scoping process to prepare a supplement the to the final environmental impact statement (FEIS) on the construction permit related to the operating license application for the SHINE Medical Isotope Production Facility. The NRC is seeking public input on the proposed action and has scheduled a public scoping meeting. DATES: Submit comments by January 13, 2020. Comments received after this date will be considered if it is practical to do so, but the Commission is able to ensure consideration only for comments received before this date. ADDRESSES: You may submit comments by any of the following methods: • Federal Rulemaking Website: Go to http://www.regulations.gov and search for Docket ID NRC–2019–0173. Address questions about NRC docket IDs in Regulations.gov to Jennifer Borges; telephone: 301–287–9127; email: Jennifer.Borges@nrc.gov. For technical questions, contact the individual listed in the FOR FURTHER INFORMATION CONTACT section of this document. • Mail comments to: Office of Administration, Mail Stop: TWFN–7– A60M, U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001, ATTN: Program Management, Announcements and Editing Staff. • For additional direction on obtaining information and submitting comments, see ‘‘Obtaining Information and Submitting Comments’’ in the SUPPLEMENTARY INFORMATION section of this document. FOR FURTHER INFORMATION CONTACT: Jennifer A. Davis, Office of Nuclear Material Safety and Safeguards, U.S. Nuclear Regulatory Commission, SUMMARY: Budget. 20:21 Nov 26, 2019 BILLING CODE 7536–01–P AGENCY: Request for Comments on Improving Vulnerability Identification, Management, and Remediation VerDate Sep<11>2014 [FR Doc. 2019–25770 Filed 11–26–19; 8:45 am] SHINE Medical Technologies, LLC OFFICE OF MANAGEMENT AND BUDGET ACTION: Elizabeth Voyatzis, Committee Management Officer, National Endowment for the Humanities. [FR Doc. 2019–25715 Filed 11–26–19; 8:45 am] BILLING CODE 3110–05–P AGENCY: Humanities Act of 1965, 20 U.S.C. 951 et seq., as amended. E:\FR\FM\27NON1.SGM 27NON1 Federal Register / Vol. 84, No. 229 / Wednesday, November 27, 2019 / Notices Washington, DC 20555–0001, telephone: 301–415–3835; email: Jennifer.Davis@ nrc.gov. SUPPLEMENTARY INFORMATION: I. Obtaining Information and Submitting Comments A. Obtaining Information Please refer to Docket ID NRC–2019– 0173 when contacting the NRC about the availability of information regarding this document. You may obtain publicly-available information related to this document by any of the following methods: • Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC–2019–0173. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publiclyavailable documents online in the NRC Library at https://www.nrc.gov/readingrm/adams.html. To begin the search, select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301–415–4737, or by email to pdr.resource@nrc.gov. The ADAMS accession number for each document referenced in this document (if that document is available in ADAMS) is provided the first time that a document is referenced. SHINE Medical Technologies, LLC’s (SHINE) operating license application for the SHINE Medical Isotope Production Facility can be found in ADAMS under Package Accession No. ML19211C143. • NRC’s PDR: You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. • Library: A copy of the SHINE supplemental environmental report (ER) is available at the Hedberg Public Library, 316 South Main Street, Janesville, Wisconsin 53545. B. Submitting Comments Please include Docket ID NRC–2019– 0173 in the subject line of your comment submission in order to ensure that the NRC is able to make your comment submission available to the public in this docket. The NRC cautions you not to include identifying or contact information that you do not want to be publicly disclosed in your comment submission. The NRC will post all comment submissions at https:// www.regulations.gov as well as enter the comment submissions into ADAMS. The NRC does not routinely edit VerDate Sep<11>2014 20:21 Nov 26, 2019 Jkt 250001 comment submissions to remove identifying or contact information. If you are requesting or aggregating comments from other persons for submission to the NRC, then you should inform those persons not to include identifying or contact information that they do not want to be publicly disclosed in their comment submission. Your request should state that the NRC does not routinely edit comment submissions to remove such information before making the comment submissions available to the public or entering the comment submissions into ADAMS. II. Discussion By letter dated July 17, 2019 (ADAMS Accession No. ML19211C044), SHINE filed with the NRC, pursuant to Section 103 of the Atomic Energy Act and part 50, ‘‘Domestic Licensing of Production and Utilization Facilities,’’ of title 10 of the Code of Federal Regulations (10 CFR), an application for a 30-year operating license for the SHINE Medical Isotope Production Facility to be located in Janesville, Wisconsin (ADAMS Package Accession No. ML19211C143). In addition to general and financial information, the application included a final safety analysis report and a supplemental ER. A notice of receipt and availability of this application was previously published in the Federal Register (FR) on September 10, 2019 (84 FR 47557). A notice of acceptance of the application for docketing was published in the FR on October 15, 2019 (84 FR 55187). In accordance with the provisions of 10 CFR 2.105, ‘‘Notice of proposed action,’’ a separate notice of opportunity to file a petition for leave to intervene in a hearing will be published at a later date. SHINE has proposed to construct and operate a facility in Janesville, Wisconsin to produce molybdenum-99 through the irradiation and processing of a uranyl sulfate solution. As described in the operating license application, the proposed SHINE facility would comprise an irradiation facility and radioisotope production facility. The irradiation facility would consist of eight subcritical operating assemblies (or irradiation units) and the radioisotope production facility would consist of hot cell structures for the processing of irradiated material. By letters dated March 26 and May 31, 2013 (ADAMS Accession Nos. ML13088A192 and ML13172A361, respectively), SHINE (at the time known as SHINE Medical Technologies, Inc.) submitted a construction permit application, as updated in 2015, for its eight utilization facilities and one PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 65425 production facility (ADAMS Package Accession No. ML15258A431). The NRC issued Construction Permit No. CPMIF– 001 to SHINE on February 29, 2016 (ADAMS Package Accession No. ML16041A473), as supported by NUREG–2189, ‘‘Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility,’’ dated August 2016 (ADAMS Accession No. ML16229A140), and NUREG–2183, ‘‘Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility,’’ dated October 2015 (ADAMS Accession No. ML15288A046). In accordance with 10 CFR 51.95(b), in connection with SHINE’s operating license application, the NRC will prepare a supplement to NUREG–2183, which will update the prior environmental review. The supplement will only cover matters that differ from or reflect significant new information concerning matters discussed in NUREG–2183. III. Request for Comments This notice informs the public of the NRC’s intention to conduct scoping and prepare a supplement to NUREG–2183 as part of the review of the SHINE operating license application, and to provide the public an opportunity to participate in the environmental scoping process, as defined in 10 CFR 51.29, ‘‘Scoping-environmental impact statement and supplement to environmental impact statement.’’ The regulations in 36 CFR 800.8, ‘‘Coordination with the National Environmental Policy Act,’’ allow agencies to use their National Environmental Policy Act of 1969 (NEPA) process to fulfill the requirements of Section 106 of the National Historic Preservation Act (NHPA). Therefore, pursuant to 36 CFR 800.8(c), the NRC intends to use its NEPA process and documentation to comply with Section 106 of the NHPA in lieu of the procedures set forth at 36 CFR 800.3 through 800.6. In accordance with 10 CFR 51.53(b), SHINE submitted a supplement to its construction permit ER as part of the operating license application. The supplement updates the information presented in the previous ER submitted as part of the construction permit application. The supplemental ER was prepared pursuant to 10 CFR part 51 and is publicly available in ADAMS under Accession No. ML19211C139. The supplemental ER may also be viewed on the internet at https:// www.nrc.gov/docs/ML1921/ ML19211C139.pdf. In addition, a paper E:\FR\FM\27NON1.SGM 27NON1 65426 Federal Register / Vol. 84, No. 229 / Wednesday, November 27, 2019 / Notices copy of ER is available for public review at the Hedberg Public Library, 316 South Main Street, Janesville, Wisconsin 53545. When a FEIS has been prepared in connection with the issuance of a construction permit for a production or utilization facility, the NRC is required to prepare a supplement to the FEIS on the construction permit in connection with the issuance of an operating license in accordance with 10 CFR 51.95(b). The supplement will only cover matters that differ from the final environmental impact statement or that reflect significant new information concerning matters discussed in the final environmental impact statement. The NRC will first conduct scoping and will then prepare a draft supplement for public comment. Participation in the scoping process by members of the public and local, State, Tribal, and Federal government agencies is encouraged. The scoping process will be used to accomplish the following: a. Define the proposed action; b. Determine the scope and identify the significant issues to be analyzed in depth; c. Identify and eliminate from detailed study those issues that are peripheral or are not significant; or were covered by a prior environmental review; d. Identify any environmental assessments and other ElSs that are being or will be prepared that are related to, but are not part of, the scope of the supplement being considered; e. Identify other environmental review and consultation requirements related to the proposed action; f. Indicate the relationship between the timing of the preparation of the environmental analyses and the Commission’s tentative planning and decision-making schedule; g. Identify any cooperating agencies and, as appropriate, allocate assignments for preparation and schedules for completing the supplement; and h. Describe how the supplement will be prepared, including any contractor assistance to be used. The NRC invites the following entities to participate in scoping: a. The applicant, SHINE; b. Any Federal agency that has jurisdiction by law or special expertise with respect to any environmental impact involved or that is authorized to develop and enforce relevant environmental standards; c. Affected State and local government agencies, including those authorized to develop and enforce relevant environmental standards; VerDate Sep<11>2014 20:21 Nov 26, 2019 Jkt 250001 d. Any affected Indian Tribe; e. Any person who requests or has requested an opportunity to participate in the scoping process; and f. Any person who has petitioned or intends to petition for leave to intervene under 10 CFR 2.309. IV. Public Scoping Meeting In accordance with 10 CFR 51.26, the scoping process may include a public scoping meeting to help identify significant issues related to a proposed activity and to determine the scope of issues to be addressed. The NRC will hold a public scoping meeting for the SHINE environmental review on December 12, 2019, from 6:00 p.m. to 8:00 p.m. at The Celtic House at Glen Erin Golf Club, 1417 W Airport Rd., Janesville, WI 53546. There will be an open house one hour before the meeting for members of the public to meet with the NRC staff and sign in to speak at the meeting. The meeting will be transcribed and will include: (1) An overview by the NRC staff of the safety and NEPA environmental review processes, the proposed scope of the supplement to the FEIS; and (2) the opportunity for interested government agencies, organizations, and individuals to submit comments or suggestions on the environmental issues or the proposed scope. The main objectives of this meeting are to describe the environmental review process and receive public comments on the appropriate scope and content to be considered in the staff’s review. To be considered, comments must be provided either at the transcribed public meeting or in writing, as discussed in the ADDRESSES section of this document. Persons may register to attend or present oral comments at the meeting on the scope of the NEPA review by contacting the NRC Environmental Project Manager, Ms. Jennifer Davis, by telephone at 301–415–3835, or by email at Jennifer.Davis@nrc.gov no later than December 5, 2019. Members of the public may also register to speak during the registration period prior to the start of the meeting. Individual oral comments may be limited by the time available, depending on the number of persons who register. Members of the public who have not registered may also have an opportunity to speak if time permits. Public comments will be considered in the scoping process for the SHINE environmental review. Please contact Ms. Davis no later than December 5, 2019, if accommodations or special equipment is needed to attend or present information at the public meeting, so that the NRC staff can PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 determine whether the request can be accommodated. Participation in the scoping process does not entitle participants to become parties to the proceeding to which the supplement relates. Matters related to participation in any hearing are outside the scope of matters to be discussed at this public meeting. Dated at Rockville, Maryland, this 22nd day of November 2019. For the Nuclear Regulatory Commission. Robert B. Elliott, Chief, Environmental Review License Renewal Branch, Division of Rulemaking, Environmental, and Financial Support, Office of Nuclear Material Safety and Safeguards. [FR Doc. 2019–25788 Filed 11–26–19; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [Docket No. EA–18–130; NRC–2019–0232] In the Matter of Southern Nuclear Operating Company Nuclear Regulatory Commission. ACTION: Confirmatory Order; issuance. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) is issuing a Confirmatory Order to Southern Nuclear Operating Company (SNC). This action is based on two investigations conducted by the NRC Office of Investigations (OI), that apparent willful violations of NRC’s regulations regarding ‘‘Employee Protection,’’ occurred. Specifically, two contract employees at Vogtle Units 3 and 4 were terminated from employment in 2016 and 2017, respectively. The NRC determined that these terminations were, in part, because the contract employees engaged in protected activity. An ADR mediation session was held on August 5, 2019, with SNC, and a preliminary settlement agreement was reached. Subsequently, SNC consented to the specific actions listed in section V of the Confirmatory Order and the NRC agrees to no pursue any further enforcement action in connection with this apparent violation. The Confirmatory Order becomes effective upon issuance. DATES: The Confirmatory Order containing the agreements made between SNC and the NRC was issued on November 20, 2019. ADDRESSES: Please refer to Docket ID NRC–2019–0232 when contacting the NRC about the availability of information regarding this document. You may obtain publicly-available SUMMARY: E:\FR\FM\27NON1.SGM 27NON1

Agencies

[Federal Register Volume 84, Number 229 (Wednesday, November 27, 2019)]
[Notices]
[Pages 65424-65426]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-25788]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[Docket No. 50-608; NRC-2019-0173]


SHINE Medical Technologies, LLC

AGENCY: Nuclear Regulatory Commission.

ACTION: Intent to prepare a supplement to the final environmental 
impact statement and conduct scoping.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) intends to gather 
information through the public scoping process to prepare a supplement 
the to the final environmental impact statement (FEIS) on the 
construction permit related to the operating license application for 
the SHINE Medical Isotope Production Facility. The NRC is seeking 
public input on the proposed action and has scheduled a public scoping 
meeting.

DATES: Submit comments by January 13, 2020. Comments received after 
this date will be considered if it is practical to do so, but the 
Commission is able to ensure consideration only for comments received 
before this date.

ADDRESSES: You may submit comments by any of the following methods:
     Federal Rulemaking Website: Go to http://www.regulations.gov and search for Docket ID NRC-2019-0173. Address 
questions about NRC docket IDs in Regulations.gov to Jennifer Borges; 
telephone: 301-287-9127; email: [email protected]. For technical 
questions, contact the individual listed in the FOR FURTHER INFORMATION 
CONTACT section of this document.
     Mail comments to: Office of Administration, Mail Stop: 
TWFN-7-A60M, U.S. Nuclear Regulatory Commission, Washington, DC 20555-
0001, ATTN: Program Management, Announcements and Editing Staff.
     For additional direction on obtaining information and 
submitting comments, see ``Obtaining Information and Submitting 
Comments'' in the SUPPLEMENTARY INFORMATION section of this document.

FOR FURTHER INFORMATION CONTACT: Jennifer A. Davis, Office of Nuclear 
Material Safety and Safeguards, U.S. Nuclear Regulatory Commission,

[[Page 65425]]

Washington, DC 20555-0001, telephone: 301-415-3835; email: 
[email protected].

SUPPLEMENTARY INFORMATION:

I. Obtaining Information and Submitting Comments

A. Obtaining Information

    Please refer to Docket ID NRC-2019-0173 when contacting the NRC 
about the availability of information regarding this document. You may 
obtain publicly-available information related to this document by any 
of the following methods:
     Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC-2019-0173.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly-available documents online in the NRC 
Library at https://www.nrc.gov/reading-rm/adams.html. To begin the 
search, select ``Begin Web-based ADAMS Search.'' For problems with 
ADAMS, please contact the NRC's Public Document Room (PDR) reference 
staff at 1-800-397-4209, 301-415-4737, or by email to 
[email protected]. The ADAMS accession number for each document 
referenced in this document (if that document is available in ADAMS) is 
provided the first time that a document is referenced. SHINE Medical 
Technologies, LLC's (SHINE) operating license application for the SHINE 
Medical Isotope Production Facility can be found in ADAMS under Package 
Accession No. ML19211C143.
     NRC's PDR: You may examine and purchase copies of public 
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555 
Rockville Pike, Rockville, Maryland 20852.
     Library: A copy of the SHINE supplemental environmental 
report (ER) is available at the Hedberg Public Library, 316 South Main 
Street, Janesville, Wisconsin 53545.

B. Submitting Comments

    Please include Docket ID NRC-2019-0173 in the subject line of your 
comment submission in order to ensure that the NRC is able to make your 
comment submission available to the public in this docket.
    The NRC cautions you not to include identifying or contact 
information that you do not want to be publicly disclosed in your 
comment submission. The NRC will post all comment submissions at 
https://www.regulations.gov as well as enter the comment submissions 
into ADAMS. The NRC does not routinely edit comment submissions to 
remove identifying or contact information.
    If you are requesting or aggregating comments from other persons 
for submission to the NRC, then you should inform those persons not to 
include identifying or contact information that they do not want to be 
publicly disclosed in their comment submission. Your request should 
state that the NRC does not routinely edit comment submissions to 
remove such information before making the comment submissions available 
to the public or entering the comment submissions into ADAMS.

II. Discussion

    By letter dated July 17, 2019 (ADAMS Accession No. ML19211C044), 
SHINE filed with the NRC, pursuant to Section 103 of the Atomic Energy 
Act and part 50, ``Domestic Licensing of Production and Utilization 
Facilities,'' of title 10 of the Code of Federal Regulations (10 CFR), 
an application for a 30-year operating license for the SHINE Medical 
Isotope Production Facility to be located in Janesville, Wisconsin 
(ADAMS Package Accession No. ML19211C143). In addition to general and 
financial information, the application included a final safety analysis 
report and a supplemental ER. A notice of receipt and availability of 
this application was previously published in the Federal Register (FR) 
on September 10, 2019 (84 FR 47557). A notice of acceptance of the 
application for docketing was published in the FR on October 15, 2019 
(84 FR 55187). In accordance with the provisions of 10 CFR 2.105, 
``Notice of proposed action,'' a separate notice of opportunity to file 
a petition for leave to intervene in a hearing will be published at a 
later date.
    SHINE has proposed to construct and operate a facility in 
Janesville, Wisconsin to produce molybdenum-99 through the irradiation 
and processing of a uranyl sulfate solution. As described in the 
operating license application, the proposed SHINE facility would 
comprise an irradiation facility and radioisotope production facility. 
The irradiation facility would consist of eight subcritical operating 
assemblies (or irradiation units) and the radioisotope production 
facility would consist of hot cell structures for the processing of 
irradiated material.
    By letters dated March 26 and May 31, 2013 (ADAMS Accession Nos. 
ML13088A192 and ML13172A361, respectively), SHINE (at the time known as 
SHINE Medical Technologies, Inc.) submitted a construction permit 
application, as updated in 2015, for its eight utilization facilities 
and one production facility (ADAMS Package Accession No. ML15258A431). 
The NRC issued Construction Permit No. CPMIF-001 to SHINE on February 
29, 2016 (ADAMS Package Accession No. ML16041A473), as supported by 
NUREG-2189, ``Safety Evaluation Report Related to SHINE Medical 
Technologies, Inc. Construction Permit Application for a Medical 
Radioisotope Production Facility,'' dated August 2016 (ADAMS Accession 
No. ML16229A140), and NUREG-2183, ``Environmental Impact Statement for 
the Construction Permit for the SHINE Medical Radioisotope Production 
Facility,'' dated October 2015 (ADAMS Accession No. ML15288A046). In 
accordance with 10 CFR 51.95(b), in connection with SHINE's operating 
license application, the NRC will prepare a supplement to NUREG-2183, 
which will update the prior environmental review. The supplement will 
only cover matters that differ from or reflect significant new 
information concerning matters discussed in NUREG-2183.

III. Request for Comments

    This notice informs the public of the NRC's intention to conduct 
scoping and prepare a supplement to NUREG-2183 as part of the review of 
the SHINE operating license application, and to provide the public an 
opportunity to participate in the environmental scoping process, as 
defined in 10 CFR 51.29, ``Scoping-environmental impact statement and 
supplement to environmental impact statement.''
    The regulations in 36 CFR 800.8, ``Coordination with the National 
Environmental Policy Act,'' allow agencies to use their National 
Environmental Policy Act of 1969 (NEPA) process to fulfill the 
requirements of Section 106 of the National Historic Preservation Act 
(NHPA). Therefore, pursuant to 36 CFR 800.8(c), the NRC intends to use 
its NEPA process and documentation to comply with Section 106 of the 
NHPA in lieu of the procedures set forth at 36 CFR 800.3 through 800.6.
    In accordance with 10 CFR 51.53(b), SHINE submitted a supplement to 
its construction permit ER as part of the operating license 
application. The supplement updates the information presented in the 
previous ER submitted as part of the construction permit application. 
The supplemental ER was prepared pursuant to 10 CFR part 51 and is 
publicly available in ADAMS under Accession No. ML19211C139. The 
supplemental ER may also be viewed on the internet at https://www.nrc.gov/docs/ML1921/ML19211C139.pdf. In addition, a paper

[[Page 65426]]

copy of ER is available for public review at the Hedberg Public 
Library, 316 South Main Street, Janesville, Wisconsin 53545.
    When a FEIS has been prepared in connection with the issuance of a 
construction permit for a production or utilization facility, the NRC 
is required to prepare a supplement to the FEIS on the construction 
permit in connection with the issuance of an operating license in 
accordance with 10 CFR 51.95(b). The supplement will only cover matters 
that differ from the final environmental impact statement or that 
reflect significant new information concerning matters discussed in the 
final environmental impact statement.
    The NRC will first conduct scoping and will then prepare a draft 
supplement for public comment. Participation in the scoping process by 
members of the public and local, State, Tribal, and Federal government 
agencies is encouraged. The scoping process will be used to accomplish 
the following:
    a. Define the proposed action;
    b. Determine the scope and identify the significant issues to be 
analyzed in depth;
    c. Identify and eliminate from detailed study those issues that are 
peripheral or are not significant; or were covered by a prior 
environmental review;
    d. Identify any environmental assessments and other ElSs that are 
being or will be prepared that are related to, but are not part of, the 
scope of the supplement being considered;
    e. Identify other environmental review and consultation 
requirements related to the proposed action;
    f. Indicate the relationship between the timing of the preparation 
of the environmental analyses and the Commission's tentative planning 
and decision-making schedule;
    g. Identify any cooperating agencies and, as appropriate, allocate 
assignments for preparation and schedules for completing the 
supplement; and
    h. Describe how the supplement will be prepared, including any 
contractor assistance to be used.
    The NRC invites the following entities to participate in scoping:
    a. The applicant, SHINE;
    b. Any Federal agency that has jurisdiction by law or special 
expertise with respect to any environmental impact involved or that is 
authorized to develop and enforce relevant environmental standards;
    c. Affected State and local government agencies, including those 
authorized to develop and enforce relevant environmental standards;
    d. Any affected Indian Tribe;
    e. Any person who requests or has requested an opportunity to 
participate in the scoping process; and
    f. Any person who has petitioned or intends to petition for leave 
to intervene under 10 CFR 2.309.

IV. Public Scoping Meeting

    In accordance with 10 CFR 51.26, the scoping process may include a 
public scoping meeting to help identify significant issues related to a 
proposed activity and to determine the scope of issues to be addressed. 
The NRC will hold a public scoping meeting for the SHINE environmental 
review on December 12, 2019, from 6:00 p.m. to 8:00 p.m. at The Celtic 
House at Glen Erin Golf Club, 1417 W Airport Rd., Janesville, WI 53546. 
There will be an open house one hour before the meeting for members of 
the public to meet with the NRC staff and sign in to speak at the 
meeting.
    The meeting will be transcribed and will include: (1) An overview 
by the NRC staff of the safety and NEPA environmental review processes, 
the proposed scope of the supplement to the FEIS; and (2) the 
opportunity for interested government agencies, organizations, and 
individuals to submit comments or suggestions on the environmental 
issues or the proposed scope. The main objectives of this meeting are 
to describe the environmental review process and receive public 
comments on the appropriate scope and content to be considered in the 
staff's review. To be considered, comments must be provided either at 
the transcribed public meeting or in writing, as discussed in the 
ADDRESSES section of this document.
    Persons may register to attend or present oral comments at the 
meeting on the scope of the NEPA review by contacting the NRC 
Environmental Project Manager, Ms. Jennifer Davis, by telephone at 301-
415-3835, or by email at [email protected] no later than December 
5, 2019. Members of the public may also register to speak during the 
registration period prior to the start of the meeting. Individual oral 
comments may be limited by the time available, depending on the number 
of persons who register. Members of the public who have not registered 
may also have an opportunity to speak if time permits. Public comments 
will be considered in the scoping process for the SHINE environmental 
review. Please contact Ms. Davis no later than December 5, 2019, if 
accommodations or special equipment is needed to attend or present 
information at the public meeting, so that the NRC staff can determine 
whether the request can be accommodated.
    Participation in the scoping process does not entitle participants 
to become parties to the proceeding to which the supplement relates. 
Matters related to participation in any hearing are outside the scope 
of matters to be discussed at this public meeting.

    Dated at Rockville, Maryland, this 22nd day of November 2019.

    For the Nuclear Regulatory Commission.
Robert B. Elliott,
Chief, Environmental Review License Renewal Branch, Division of 
Rulemaking, Environmental, and Financial Support, Office of Nuclear 
Material Safety and Safeguards.
[FR Doc. 2019-25788 Filed 11-26-19; 8:45 am]
BILLING CODE 7590-01-P